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Summary
Progenitors in the developing central nervous system
acquire neural potential and proliferate to expand the
pool of precursors competent to undergo neuronal
differentiation. The formation and maintenance of
neural-competent precursors are regulated by SoxB1
transcription factors, and evidence that their expres-
sion is regionally regulated suggests that specific
signals regulate neural potential in subdomains of the
developing nervous system. We show that the frizzled
(Fz) transmembrane receptor Xfz5 selectively gov-
erns neural potential in the developing Xenopus ret-
ina by regulating the expression of Sox2. Blocking
either Xfz5 or canonical Wnt signaling within the de-
veloping retina inhibits Sox2 expression, reduces cell
proliferation, inhibits the onset of proneural gene ex-
pression, and biases individual progenitors toward a
nonneural fate, without altering the expression of
multiple progenitor markers. Blocking Sox2 function
mimics these effects. Rescue experiments indicate
that Sox2 is downstream of Xfz5. Thus, Fz signaling
can regulate the neural potential of progenitors in the
developing nervous system.
Introduction
Neural fate specification is a tightly regulated process
that relies upon the interplay between extrinsic signals
and intrinsic factors to regulate the genesis of specific
classes of neurons in a spatially and temporally coordi-
nated manner (Edlund and Jessell, 1999). Secreted, cell
surface, or transmembrane signals can act to regulate
essential properties of progenitors by modulating the
expression or function of transcription factors, resulting
in fundamental changes in gene expression. One key
feature of nervous system development is that progeni-
tors within a given region of the central nervous system*Correspondence: monica.vetter@neuro.utah.edu
4These authors contributed equally to this work.(CNS) must acquire and maintain neural potential to ini-
tiate the expression of factors required for neurogen-
esis. Much attention has focused on intrinsic regulators
of neural potential. For example, Group B1 Sox genes
(SoxB1), which include Sox1-3 in vertebrates and
dichaete and soxneuro (soxn) in Drosophila, play a criti-
cal role in neural specification and then function to
maintain a population of undifferentiated neural precur-
sors (Buescher et al., 2002; Bylund et al., 2003; Crem-
azy et al., 2000; Graham et al., 2003; Kishi et al., 2000;
Mizuseki et al., 1998; Overton et al., 2002; Sasai, 2001).
Although SoxB1 genes are broadly expressed through-
out progenitors in the developing nervous system,
SoxB1 gene expression is initiated early in response to
neural-inducing signals from the organizer, but later
gene expression in different regions of the developing
nervous system appears to be under the control of dis-
tinct cis-regulatory elements (Uchikawa et al., 2003).
This raises the possibility that region-specific signaling
pathways could modulate SoxB1 gene expression and
thus regionally regulate neural potential. Although mul-
tiple organizer-derived signals have been identified (De
Robertis and Kuroda, 2004), extrinsic signals that regu-
late neural potential later in nervous system develop-
ment have not been described. Candidate signals in-
clude secreted Wnt ligands, which bind to Frizzled
receptors and activate several intracellular signaling
pathways, including the planar cell polarity pathway,
the calcium pathway, and the β-catenin (or canonical)
pathway (for reviews, see Moon et al., 2002; Strutt,
2003; Veeman et al., 2003). Wnt ligands and Frizzled
receptors are widely expressed in the nervous system
at multiple stages of development, suggesting that they
play diverse roles, including regulation of neural pat-
terning and proliferation (Patapoutian and Reichardt,
2000). However, it is not known whether this pathway
can regulate the neural potential of CNS progenitors.
Vertebrate retinal development has served as an im-
portant model for understanding the signals governing
the progression of neurogenesis within the CNS. Pro-
genitors within the developing eye are defined by the
expression of transcription factors that confer eye iden-
tity, including the homeodomain factors Rx, Pax6, Six3,
and Six6 (Zuber et al., 2003), as well as Chx10, which
is restricted to the neural retina domain (Belecky-
Adams et al., 1997; Burmeister et al., 1996; Liu et al.,
1994). During retinal development, progenitors increase
their rate of proliferation and expand the progenitor
population, thus providing sufficient numbers of cells
to populate the mature retina (Dyer, 2003; Dyer and
Cepko, 2001; Levine and Green, 2004). Progenitors
subsequently commence expression of genes required
for retinal neurogenesis, including genes encoding
proneural basic helix-loop-helix transcription factors,
which regulate retinal neuron differentiation, and genes
for neurogenic proteins, such as the Notch receptor or
the ligand Delta, which act to constrain neuronal differ-
entiation of progenitors (Dorsky et al., 1995; Dorsky et
al., 1997; Perron and Harris, 2000a). Thus, in order for
retinal neurons to be generated, multipotent retinal pro-
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24genitor cells must proliferate and also be competent to g
tinitiate expression of proneural and neurogenic genes.
Since multiple steps in eye development are well de- X
rfined at the molecular level, retinal development pro-
vides an ideal system for investigating whether specific X
tsignals regulate the proliferation and neural potential
of progenitors. w
SWhat are the factors that control neural potential in
the developing retina, and are there specific signals m
eregulating their expression? Sox2 is expressed in the
developing neural retina, suggesting an important role a
efor this gene in retinal neurogenesis (Kamachi et al.,
1998; Mizuseki et al., 1998). Consistent with this, hu- (
rman mutations in the Sox2 gene have been identified
in individuals with anophthalmia (Fantes et al., 2003). r
aSox2 is broadly expressed in the developing CNS, but
analysis of the chick Sox2 promoter suggests that its r
eexpression is regulated by five conserved enhancers,
each of which functions within a different region of the c
inervous system, including one that promotes expres-
sion within the developing eye (Uchikawa et al., 2003). r
This suggests that retina-specific signals may regulate
the expression of Sox2 during eye development and i
tthus control neural potential within this tissue; however,
the nature of these signals remains undefined. Numer- d
Uous components of the Wnt/Frizzled signaling pathway
are expressed during retinal development (Fuhrmann et m
wal., 2003; Jin et al., 2002; Liu et al., 2003). In particular,
Xenopus Frizzled 5 (Xfz5) is expressed in the presump- 8
otive neural retina starting at late neurula stages during
early optic vesicle formation and is thus poised to influ- i
tence the differentiation of progenitors in the early neu-
ral retina (Sumanas and Ekker, 2001). m
UIn this study, we provide evidence that Xfz5 acts
through canonical β-catenin signaling to regulate the p
fproliferation and neural potential of retinal progenitors
and that it does so by regulating the regional expres- t
osion of the neural competence factor Sox2. Blocking
either Xfz5 or canonical Wnt signaling did not affect the a
texpression of multiple retinal progenitor markers but in-
stead inhibited the expression of Sox2, resulting in re- (
iduced cell proliferation and a failure to properly initiate
the expression of proneural genes required for neuro- G
rgenesis. Blocking Sox2 had similar effects, suggesting
that the expression of this gene is required for progeni- I
ctors to adopt a more rapidly proliferating neural-com-
petent state. When either Xfz5 or Sox2 was blocked (
swithin individual retinal progenitors, they were biased
toward adopting the nonneural Mu¨ller glial fate. Thus, a
twe conclude that Xfz5 regulates the neural potential of
progenitors in the developing Xenopus retina. d
c
sResults
a
oXfz5 Is Expressed in the Developing Retina
Sand Is Required for Retinal Development
(To understand the signals that may regulate the neural
properties of retinal progenitors, we considered the
Wnt signaling pathway, which has been implicated in I
Pregulating several aspects of nervous system develop-
ment (Patapoutian and Reichardt, 2000). Although mul- E
2tiple components of this pathway are expressed in the
developing eye, its role in eye development is just be- Minning to be explored (Van Raay and Vetter, 2004). We
herefore investigated the expression and function of
fz5, which is expressed in the eye starting at late neu-
ula stages (Sumanas and Ekker, 2001). We found that
fz5 expression began at stage 17 in the emerging op-
ic vesicles (Figure 1A). Expression of Xfz5 persisted
ithin the developing neural retina (Figures 1B and 1C;
umanas and Ekker, 2001) but decreased as cells ter-
inally differentiated. By stage 41, Xfz5 expression was
xcluded from the central retina, which is postmitotic
nd fully differentiated (Figure 1D). At this stage, Xfz5
xpression was restricted to the ciliary marginal zone
CMZ), which contains a spatial gradient of cells that
ecapitulates embryonic retinogenesis, with multipotent
etinal progenitor cells located at the peripheral edge
nd differentiating neurons located more centrally (Har-
is and Perron, 1998; Perron and Harris, 2000b; Perron
t al., 1998). Xfz5 expression within the CMZ was ex-
luded from the most peripheral cells, suggesting that
t functions within progenitors dedicated to the neural
etina lineage.
To investigate the function of XFz5, we designed two
ndependent morpholino (MO) antisense oligonucleo-
ides to inhibit Xfz5 mRNA translation. The ATG MO was
esigned over the ATG start codon of Xfz5, while the
TR MO was designed within the 5#UTR (see Experi-
ental Procedures). When 10 ng of the Xfz5 ATG MO
as injected into one dorsal animal blastomere at the
-cell stage together with RNA encoding eGFP, 73%
f the embryos had a dramatically reduced eye on the
njected side (Figures 1E–1I; n = 125/171). The pheno-
ype was restricted to the eye, since the nasal cavity,
outh, and otic vesicles appeared unaffected. The Xfz5
TR MO (10 ng) produced a similar but less penetrant
henotype (50% with reduced eye size; n = 54). In the
ollowing analyses, we saw similar phenotypes using
hese two independent morpholinos, so we show data
nly for the ATG MO, which will be referred to simply
s Xfz5 MO. There were no effects with a standard con-
rol MO or a Xfz5 ATG MO containing five mismatches
data not shown). The Xfz5 ATG MO could efficiently
nhibit expression of GFP when it was coinjected with
FP RNA in which the Xfz5 ATG MO target sequence
eplaced the eGFP ATG start codon (data not shown).
n addition, we could rescue the small eye phenotype
aused by the Xfz5 UTR MO by coinjecting Xfz5 RNA
500 pg) lacking the MO target sequence (11% with
maller eye [n= 64] versus 50% with the Xfz5 UTR MO
lone [n = 54]). Overexpression of Xfz5 alone by injec-
ion of either 300 pg or 1 ng of RNA at the 8-cell stage
id not increase retinal size at stage 41 or cause any
hange in retinal gene expression at optic vesicle
tages (data not shown). This is perhaps due to limited
vailability of Wnt ligand or other signaling components
r to negative regulation by soluble inhibitors such as
FRP2, which is highly expressed in the developing eye
Liu et al., 2003).
nhibition of Xfz5 Causes Reduced
roliferation within the Optic Vesicle
ye size was reduced by stage 23, and we observed
7% fewer cells within the optic vesicle on the Xfz5
O-injected side (Figure 2A), but no increase in cell
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25Figure 1. Xfz5 Is Expressed in the Devel-
oping Retina and Is Required for Normal
Eye Development
Xfz5 is expressed in the early optic vesicle
starting at stage 17 (A) and continues to be
strongly expressed in the eye at stage 21 (B)
and stage 31 (C). Retinal sections at stage
41 (D) show Xfz5 is expressed within the
CMZ but not in the peripheral region (brack-
ets). (E–I) Reduced eye size following Xfz5
MO (Xfz5 ATG) injection at the 8-cell stage.
(E) Uninjected side. (F) Xfz5 MO-injected
side. Embryo marked with an asterisk is
shown in dorsal views in (G)–(I). (G) Bright-
field view. (H) eGFP expression marks in-
jected side. (I) merge of (G) and (H).n = 17 embryos). There was no difference in HP3 stain- which makes a small contribution to the retina (Huang
Figure 2. Inhibition of Xfz5 Causes Reduced Cell Number and Decreased Mitosis in the Optic Vesicle
(A) Reduced cell number on the Xfz5 MO-injected side versus uninjected side (control). Cell counts from a single section through the central
part of the distal optic vesicle at stage 23/24. n = 15 embryos. (B) All optic vesicle cells on the Xfz5 MO-injected side are labeled by a 4 hr
pulse of BrDU (brown), as confirmed by Hoechst staining (C), since the BrDU stain quenches the fluorescent signal (blue). (D) Reduced
number of phosphohistone H3 (HP3) labeled cells within the optic vesicle (stage 23/24) on the Xfz5 MO-injected side compared to the
uninjected side (control). n = 17 embryos. (E) Retinal clone size is reduced by the Xfz5 MO. GFP RNA was injected into blastomere V1.2.1
either alone (GFP; n = 9) or together with Xfz5 ATG MO (n = 9), the Xfz5 ATG mismatch MO (n = 5), the Xfz5 UTR MO (n = 5), or the Xfz5 UTR
MO plus 500 pg of Xfz5 RNA lacking the MO target sequence (n = 6). The number of GFP-labeled cells was counted in six central retinal
sections at stage 41 for each embryo. In (A), (D), and (E), error bars represent SEM; *p < 0.001 by Student’s t test compared to either
uninjected control side in (A) and (D) or GFP alone in (E).death as marked by TUNEL staining of Xfz5 MO-
injected (n = 17 embryos) compared to control embryos
(n = 12; data not shown). There was no premature cell
cycle exit, since we were able to label virtually every
cell in the optic vesicle on both the control and Xfz5
MO-injected sides with a 4 hr pulse of BrDU (Figures
2B and 2C). However, we observed a 70% decrease
in the number of cells positive for the mitotic marker
phosphohistone 3 (HP3) within the eye domain on the
Xfz5 MO-injected side (Figure 2D). Since there were on
average 27% fewer cells on the Xfz5 MO-injected side
(Figure 2A), we adjusted the number of HP3+ cells on
the control side by 27% (adjusted n = 7.2 HP3+ cells
versus unadjusted n = 9.8 HP3+ cells) and found that
the difference compared to the Xfz5 MO-injected side
(n = 2.9 HP3+ cells) was still highly significant (p < 0.01,ing outside the eye domain (data not shown). Wnt/Fz
signaling has been shown to regulate proliferation in
the CNS by regulating expression of Cyclin D1 (Mega-
son and McMahon, 2002), but we found no changes in
the levels of Cyclin D1 expression within the developing
eye (see Figure S1A in the Supplemental Data available
with this article online).
Since we observed that every cell in the retina was
proliferating, but that the number of mitotic cells was
reduced by the Xfz5 MO, we reasoned that the cells
may be proliferating more slowly. This would predict
that expansion of the progenitor population within the
retina would be reduced when Xfz5 is inhibited. We per-
formed retinal clone size analysis by injecting mRNA
for GFP either alone (300 pg) or together with the Xfz5
MO (2.5 ng) at the 32-cell stage into blastomere V1.2.1,
Neuron
26and Moody, 1993). The number of GFP-labeled cells in S
Xthe retinal clone was then assessed on sections at
istage 41. Coinjection of either the Xfz5 ATG MO or the
fXfz5 UTR MO caused a 60% reduction in the size of
rthe retinal clone compared to injection of GFP mRNA
salone, while a Xfz5 ATG MO containing five mismatches
ehad no significant effect on clone size (Figure 2E). Fur-
pthermore, the reduced retinal clone size observed with
the Xfz5 UTR MO could be restored by coinjection of
tXfz5 RNA (500 pg) lacking the MO target sequence in
athe 5# UTR (Figure 2E). Although multiple factors can
1contribute to retinal clone size following blastomere in-
tjections at early cleavage stages, Xfz5 is selectively ex-
lpressed in the developing neural retina, and the effects
aof the MO could be rescued, supporting the conclusion
3that proliferation of progenitor cells within the retina is
Xreduced when Xfz5 function is blocked.
t
aXfz5 Inhibition Delays the Initiation of Neurogenic
w
and Proneural Gene Expression
s
Retinal progenitor proliferation has been shown to de-
(
pend upon multiple factors, including progenitor-spe- g
cific homeobox transcription factors. We thus asked M
whether blocking Xfz5 function affects the expression 6
of retinal progenitor genes. At stage 17, which is just at s
the onset of Xfz5 expression, we saw no changes in the 1
expression of the retinal homeobox gene Rx (Mathers M
et al., 1997), which marks the early eye field, or the ho- 8
meodomain gene Engrailed-2 (En), which marks the X
midbrain/hindbrain junction, (Hemmati-Brivanlou et al., r
1991), suggesting that eye field and embryo patterning M
is unaffected by the Xfz5 MO (Figure S1B; n = 20). d
Within the optic vesicle (at stage 23), we found that the t
intensity of expression of retinal progenitor genes Rx, r
Pax6, Six6, Chx10, and Six3 was unaltered by the Xfz5 C
MO, although the domain of expression was reduced q
due to smaller eye size (Figures 3A–3D and Figure g
rS1C; n = 32/39 for Rx, n = 33/34 for Pax6, n = 34/34 forFigure 3. Inhibition of Xfz5 Results in Normal
Eye Patterning but Decreased Expression of
Genes Involved in Retinal Neurogenesis
The Xfz5 MO results in a smaller expression
domain for Rx (A), Pax6 (B), Six6 (C), Chx10
(D), and Xfz5 (E), but the relative levels of ex-
pression are unchanged compared to the con-
trol side. En expression (arrowhead in [A]) is
unchanged. Expression of Xdelta-1 (F–H),
X-Notch-1 (I–K), Xash3 (L–N), XNgnR-1 (O
and P), Xath5 (Q and R), and XBrn3d (S and
T) are suppressed on the Xfz5 MO-injected
side. Arrow indicates injected side.ix6, n = 24/25 for Chx10, and n = 65/70 for Six3). The
fz5 MO did not alter the intensity of expression of Xfz5
tself (Figure 3E; n = 53/53 for Xfz5). Thus, blocking Xfz5
unction causes reduced proliferation without loss of
etinal homeobox gene expression or Cyclin D1 expres-
ion. This is consistent with the fact that during normal
ye development, Xfz5 expression initiates after the ex-
ression of these retinal progenitor genes.
Xfz5 expression in the optic vesicle commences prior
o the onset of neurogenic and proneural genes, which
re required for retinal neurogenesis (Perron et al.,
998), raising the possibility that Xfz5 plays a role in
his process. We observed a dramatic reduction in the
evel of expression of the neurogenic genes Xdelta-1
nd X-Notch-1 on the Xfz5 MO-injected side (Figures
F–3K; 73%, n = 70 for Xdelta-1; 60%, n = 32 for
-Notch-1). In some cases, expression was almost en-
irely absent in the eye on the injected side. X-Notch-1
nd Xdelta-1 expression in domains around the eye
ere not perturbed, suggesting that the phenotype is
pecific to the domain where Xfz5 normally functions
Figures 3F–3K). Expression of the early proneural
enes Xash3 and Xash1 was also inhibited on the Xfz5
O-injected side (Figures 3L–3N and data not shown;
8%, n = 81 for Xash3; 72%, n = 50 for Xash1). Expres-
ion of the later proneural genes X-neurogenin related
(XNgnR1) and Xath5 was also suppressed on the Xfz5
O-injected side at stage 28 (Figures 3O–3R; 50%, n =
for XNgnR1; 61%, n = 36 for Xath5). Expression of
Brn3d, a homeobox factor expressed in differentiating
etinal ganglion cells (RGCs), was inhibited by the Xfz5
O (Figures 3S and 3T; 71%, n = 7). Together, these
ata demonstrate that in the absence of Xfz5 function,
he progenitors within the optic vesicle assume normal
etinal identity, as demonstrated by Rx, Pax6, Six6,
hx10, Six3, and Xfz5 expression, but that the subse-
uent onset of the neurogenic and early proneural
enes is inhibited, suggesting a failure to adopt a neu-
al-competent state.
Xfz5 Regulates Neural Potential
27The suppression of proneural and neurogenic gene
expression by the Xfz5 MO was transient, resulting in a
delay rather than a complete loss of gene expression
within the developing eye (data not shown). We rea-
soned that the efficacy of the MO may decay or that
the continued expression of Xfz5 (see Figure 2E) may
effectively titrate out the Xfz5 MO over time. To test this
hypothesis, we injected increasing amounts of the Xfz5
MO and found that at higher doses we further delayed
the recovery of proneural or neurogenic gene expres-
sion and also generated increasingly smaller eyes (Fig-
ure S2). Consistent with the delay in gene expression
caused by the Xfz5 MO, there was an apparent delay
in retinal development at later stages. At stage 41, the
neural retina was properly laminated on the Xfz5 MO-
injected side and there was normal expression of cell
type-specific markers such as Pax6 (which marks
amacrine and ganglion cells) and rhodopsin (which
marks rod photoreceptors). However, the retina was
smaller, the CMZ region appeared larger, and there was
persistence of BrDU-labeled cells in the central retina,
reminiscent of a more immature retina (see Figure S3).
Xfz5 Is Required for Normal Expression
of Sox2 in the Eye
In the absence of Xfz5 function, retinal progenitor
genes are expressed normally, but retinal neurogenesis
appears to be inhibited. This supports the idea that reti-
nal cells acquire retinal progenitor identity but fail to
become committed retinal neural precursors capable of
initiating proneural gene expression. Sox2 in Xenopus
(Kishi et al., 2000) and its fly orthologs soxneuro and
dichaete (Buescher et al., 2002; Cremazy et al., 2000;
Overton et al., 2002) are required for the onset of
proneural gene expression and commitment to the neu-
ral fate. In addition, SoxB1-class transcription factors
have been implicated in establishing neural compe-
tence (Bylund et al., 2003; Graham et al., 2003; Sasai,
2001). Therefore, we wanted to determine whether
Sox2 is expressed at the appropriate time to be regulat-
ing retinal neurogenesis and whether Xfz5 influences its
expression. Sox2 was present in the evaginating optic
vesicles (Figure 4A) and by stage 24 was strongly ex-
pressed in the developing eye (Figure 4B). In the mature
retina (stage 41), Sox2 expression was restricted to the
CMZ, but was excluded from the most peripheral re-
gion (Figure 4C), much like Xfz5. Since Xfz5 is required
for progenitors to express proneural and neurogenic
genes, it may do so by regulating the expression of
Sox2. We observed a dramatic decrease in Sox2 ex-
pression in the optic vesicle on the Xfz5 MO-injected
side (Figures 4D–4F; 70%, n = 92). Sox2 expression in
other regions of the CNS was unaffected, suggesting
that Xfz5 is selectively required for Sox2 expression in
the developing optic vesicle.
Inhibition of Sox2 Expression Mimics the Effects
on Eye Development of Inhibiting Xfz5 Expression
If the loss of Sox2 expression is primarily responsible
for mediating the effects of the Xfz5 MO on eye devel-
opment, then directly inhibiting Sox2 expression should
show similar effects. To test this, we injected 10 ng of
a morpholino targeted against Sox2 into dorsal animalFigure 4. Xfz5 Is Required for Normal Sox2 Expression in the Op-
tic Vesicle
Sox2 expression in (A) the emerging optic vesicles (stage 20) and
(B) the developing eye (stage 24). (C) In retinal sections (stage 41),
Sox2 expression is restricted to the CMZ, but excluded from the
peripheral region (bracket). (D–F) Sox2 expression is suppressed
on the Xfz5 MO-injected side (arrow in [D] and panel [F]) compared
to the uninjected control side (E). (D) Frontal view. (E and F) Lat-
eral views.blastomeres at the 8-cell stage. When these animals
were grown until stage 41, we observed reduced or
missing eyes on the injected side in 78% of the em-
bryos (Figures 5A and 5B; n = 42 embryos), similar to
what was observed with the Xfz5 MO. This effect could
be rescued in a dose-dependent manner by coinjection
of Sox2 RNA (10 ng Sox2 MO + 300 pg Sox2 RNA 34%
had reduced eyes, n = 78; 10 ng Sox2 MO + 500 pg
Sox2 RNA 20% had reduced eyes, n = 129). In addition,
a Sox2 MO containing a 5 bp mismatch caused slightly
reduced eye size in only 11% of embryos (n = 35). Since
Sox2 is expressed throughout the CNS, with the Sox2
MO we often observed morphological effects on other
anterior CNS structures derived from the dorsal animal
blastomere injected (data not shown), which was not
observed with the Xfz5 MO. Consistent with the small
eye phenotype, there was a significant decrease in the
number of HP3+ cells at stage 23/24 within the eye do-
main on the Sox2-MO injected side compared to the
control side (Figure 5C), similar to what was observed
with the Xfz5 MO (compare to Figure 2D). We found that
on average there were 23% fewer cells within the distal
optic vesicle on the Sox2 MO-injected side (n = 3; data
not shown), so we adjusted the number of HP3+ cells
on the control side by 23% (adjusted n = 6.9 HP3+ cells
versus unadjusted n = 9 HP3+ cells) and found that the
difference compared to the Sox2 MO-injected side (n =
3.2 HP3+ cells) was still highly significant (p < 0.01, n =
8). In addition, TUNEL analysis on whole-mount em-
bryos at optic vesicle stages showed that the Sox2 MO
caused no increase in cell death within the eye (n = 15)
compared to control embryos (n = 12; data not shown).
To assess whether cells in the retina are proliferating
more slowly following inhibition of Sox2, we performed
retinal clone size analysis. Coinjection of Sox2 MO (2.5
ng) with GFP RNA (300 pg) into blastomere V1.2.1
caused a 58% reduction in the number of GFP-labeled
cells in the retina at stage 41 compared to injection of
GFP RNA alone (Figure 5D). Although this is an indirect
measure, inhibition of Sox2 expression appears to have
effects on retinal cell proliferation similar to those ob-
served with inhibition of Xfz5.
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Figure 5. Inhibiting Sox2 Expression Has a Similar Effect on Eye
Development as Inhibiting Xfz5 Expression
(A and B) Reduced eye size with Sox2 MO injection at the 8-cell E
stage. (C) Sox2 MO injection causes reduction in anti-phosphohi- a
stone H3 (HP3) staining within the optic vesicle at stage 23/24.
FUninjected side is the control. n = 8 embryos. (D) Retinal clone size
pis reduced by the Sox2 MO. GFP RNA was coinjected, and the
inumber of GFP-labeled cells was counted in six central retinal sec-
tions for each embryo (n = 9 embryos). In (C) and (D), error bars T
represent SEM; *p < 0.001 by Student’s t test. Sox2 MO does not m
affect the intensity of Sox2 (E), Xfz5 (F), Rx (G), Pax6 (H), Six6 (I), t
and Chx10 (J) expression within the optic vesicle. En expression w
(arrowhead in [G]) is unchanged. The Sox2 MO suppresses the reti-
1nal expression of Xash3 (K) and Xdelta-1 (L). Injected side is on the
mright (arrow).
t
e
These results suggest that Sox2 may be primarily re- t
sponsible for mediating the regulation of neural poten- T
tial by Xfz5 signaling. This would predict that neural m
precursor gene expression should also be dependent 6
upon Sox2. We found that injection of a Sox2 MO did p
not affect the RNA levels of Sox2 itself or Xfz5 within t
the optic vesicle (87% for Sox2, n = 32; 98% for Xfz5, b
n = 41), consistent with Xfz5 acting upstream of Sox2 (
(Figures 5E and 5F). As seen for the Xfz5 MO, the Sox2 w
(MO resulted in a smaller eye domain on the injectedide, but did not affect intensity of expression of Rx or
n, suggesting that retinal progenitors are specified
nd the nervous system is patterned normally (Figure
G; 98%, n = 56). Similarly, intensity of expression of
he retinal progenitor genes Pax6, Six6, Chx10, and Six3
ppeared unaltered by the Sox2 MO, although the do-
ain of expression was reduced (Figures 5H–5J and
igure S1D; n = 33/33 for Pax6, n = 23/23 for Six6, 22/
3 for Chx10, and n = 36/37 for Six3). However, the Sox2
O dramatically inhibited expression of Xash3 (Figure
K; 82%, n = 55) and Xdelta-1 (Figure 5L; 85%, n = 71).
hus, blocking Sox2 expression has strikingly similar
ffects on eye development and neural gene expres-
ion as blocking Xfz5 expression. In addition, Xfz5 is
equired for normal Sox2 expression, but not vice versa.
hese findings support the conclusion that Xfz5 regu-
ates the expression of Sox2, which is required for reti-
al progenitors to be neural competent and initiate
roneural and neurogenic gene expression.
To assess whether the effects on eye development
ue to the Xfz5 MO can be rescued by restoring Sox2
xpression, we coinjected Sox2 mRNA (100 pg) to-
ether with 10 ng of the Xfz5 MO. We found a 50%
eduction in the number of embryos with reduced eye
ize (35%, n = 88 versus 73% with the Xfz5 MO alone)
nd the effects on eye development were less severe
ompared to those observed with injection of the Xfz5
O alone (data not shown). In addition, we found Sox2
RNA could also rescue the reduction in HP3+ cells in
he optic vesicle caused by the Xfz5 MO. We found only
25% decrease in HP3+ cells on the Xfz5MO + Sox2
NA-injected side (9.4 ± 0.7 cells control side, 7.1 ± 0.6
ells injected side; n = 26) compared to a 70% decrease
ith the Xfz5 MO alone (Figure 2D). Thus, Sox2 can
artially rescue the eye size defects associated with
nhibition of Xfz5, potentially by rescuing the effects on
rogenitor cell proliferation. The converse was not true;
hat is, 90% of Sox2 MO-injected embryos still had sig-
ificantly reduced eye size on the injected side when
oinjected with 500 pg of Xfz5 RNA (n = 62).
CF/Lef Signaling Is Active in the Developing
ye and Is Required for Eye Development
nd Neural Precursor Gene Expression
rizzled receptors have been shown to activate multi-
le signaling pathways, including the planar cell polar-
ty pathway, the Ca2+ pathway, and the Wnt/β-catenin/
CF pathway, raising the question of which pathway is
ediating the effects of Xfz5. Fz5 is capable of activa-
ing Wnt/β-catenin/TCF signaling in Xenopus embryos
hen coexpressed with specific Wnt ligands (He et al.,
997), making this pathway a likely possibility. To deter-
ine whether TCF/Lef-dependent signaling is active in
he developing eye, we generated transgenic Xenopus
mbryos (Kroll and Amaya, 1996) carrying a reporter
ransgene (TOP:dGFP) consisting of four consensus
CF/Lef binding sites coupled to a basal c-fos pro-
oter driving expression of destabilized GFP (Figure
A; Dorsky et al., 2002). By in situ hybridization at ap-
roximately stage 20, we first detected TOP:dGFP
ransgene expression (Figure 6B; 29%, n = 52 em-
ryos), which became more pronounced by stage 23
Figure 6C; 21%, n = 140 embryos). This is consistent
ith typical rates of transgene expression of 20%–40%
Kroll and Amaya, 1996; Hutcheson and Vetter, 2002). If
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Is Active in the Developing Eye and Is Re-
quired for Normal Eye Development
The TOP:dGFP transgene (A) is expressed in
the developing eye (arrowhead) at stage 20
(B), and stage 23 (C), as revealed by in situ
hybridization. The midbrain/hindbrain bound-
ary is marked by En expression (arrow in [B])
or reporter expression (arrow in [C]). (D) Rx
promoter driving N-Tcf3 tagged with GFP
(Rx:N-Tcf3-GFP). (E) GFP antibody staining
reveals transgene expression in the de-
veloping eye (stage 23). (F) Disrupted eye
development in transgenic embryos (stage
41). (G) Sections through the same embryo
reveal loss of neural retina tissue, but rem-
nants of RPE and lens (L). Section is stained
with the nuclear dye Hoechst (blue).this pathway is mediating the effects of Xfz5, then
blocking TCF/Lef-dependent signaling should have
similar effects as blocking Xfz5 function. To block TCF/
Lef signaling in the developing eye and bypass the
requirement for this pathway in axis formation and em-
bryonic patterning, we used the Xenopus Rx (Rx1A)
promoter (Zhang et al., 2003) to drive expression of a
GFP-tagged version of NTcf3, which does not re-
spond to β-catenin signaling and functions as a consti-
tutive repressor (Rx:NTcf3-GFP; Figure 6D; Molenaar
et al., 1996). We generated Rx:NTcf3-GFP transgenic
embryos, collected them at stage 23, and then stained
them with a GFP antibody to determine which embryos
expressed the transgene (Figure 6E; 53% GFP+, n =
121). Control embryos expressing GFP alone under the
control of the Rx promoter (Rx:GFP) were processed in
parallel (58% GFP+, n = 93). Another set of Rx:NTcf3-
GFP transgenic embryos were grown to stage 41 and
shown to have dramatically reduced eye size. There
was a range of effects, but in the most severely affected
embryos only residual retinal pigment epithelium (RPE)
and lens were apparent (Figures 6F and 6G; 40% re-
duced or missing eye, n = 65). Control Rx:GFP embryos
showed slightly reduced eye size in only 12% of em-
bryos at stage 41 (n = 59). To further assess whether
Wnt/β-catenin/TCF signaling is required for normal eye
development, we generated transgenic embryos ex-
pressing Axin under the control of the Rx promoter
(Rx:Axin), since axin specifically antagonizes this path-
way (Ikeda et al., 1998; Itoh et al., 1998; Sakanaka et
al., 1998). Rx:Axin transgenic embryos showed signifi-
cant eye defects at stage 41 (36% reduced or missing
eye, n = 53), similar to what was observed in
Rx:NTcf3-GFP transgenic embryos (data not shown).
To assess effects on retinal progenitor gene expres-
sion at stage 23, GFP+ transgenic embryos (either
Rx:GFP or Rx:N-Tcf3-GFP) were analyzed by in situ
hybridization. In NTcf3-GFP transgenic embryos, ex-
pression of the retinal progenitor markers Rx (Figure
7B; n = 21/21), Pax6 (Figure 7D; n = 14/14), Six6 (Figure
7F; n = 14/14), Chx10 (Figure 7H; n = 20/20), or Six3
(data not shown; n = 17/17) was unaltered compared tocontrol Rx:GFP embryos (Figures 7A, 7C, 7E, and 7G
and data not shown). However, expression of Sox2 in
the optic vesicles was either dramatically reduced or
missing in Rx:NTcf3-GFP transgenic embryos (Figure
7J; 100%, n = 26) compared to control embryos (Figure
7I; n = 21), but was unaffected in the neural tube. Simi-
larly, optic vesicle expression of Xdelta-1 was absent in
90% of Rx:NTcf3-GFP transgenic embryos and was
dramatically reduced in the remaining 10% (Figure 7L;
n = 21) compared to Rx:GFP control embryos (Figure
7K; n = 20). Thus, TCF/Lef-dependent signaling is re-
quired at precisely the same step of retinal develop-
ment as Xfz5 and likely mediates the effects of Xfz5 in
the developing eye.
Blocking Xfz5 Function Causes an Increase
in Mu¨ller Glial Differentiation
If Xfz5 is required for the neural potential of progenitors
within the developing retina, then inhibiting Xfz5 func-
tion should have specific effects on cell fate decisions
of progenitors. Since retinal progenitors fail to initiate
proneural gene expression when Xfz5 is inhibited, they
may remain in an undifferentiated state, they may delay
their differentiation, or they may adopt a nonneural fate
that is not dependent upon proneural gene expression.
To investigate the effects of Xfz5 on retinal progenitors,
we generated a dominant-negative form of the Xfz5 re-
ceptor (dnXfz5) consisting of just the soluble extracellu-
lar domain. To ensure that this dnXfz5 is behaving simi-
larly to the Xfz5 MO, we generated transgenic embryos
expressing this construct and analyzed expression of
Rx and Sox2. Since dnXfz5 was not epitope tagged, we
were not able to presort the embryos that were ex-
pressing the transgene, but our typical transgenic rates
are around 30%–40%. All of the embryos exhibited nor-
mal Rx expression (18/18; data not shown), but we ob-
served that Sox2 expression in the optic vesicles was
either dramatically reduced or missing in 33% of the
dnXfz5 embryos (n = 8/24, data not shown). Thus, ex-
pression of dnXfz5 in the optic vesicle mimics the Xfz5
MO effect and prevents Sox2 expression. To inhibit Xfz5
function within individual retinal progenitors, we co-
transfected the dnXfz5 plasmid with GFP plasmid di-
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Figure 7. TCF/Lef-Dependent Transcription Is Required for Neural
Potential of Retinal Progenitors
4
Rx:N-Tcf3-GFP transgenic embryos (stage 23) show normal ex-
c
pression of Rx and En (B) and the retinal progenitor markers Pax6
(
(D), Six6 (F), and Chx10 (H) compared to control Rx:GFP transgenic
l
embryos (A, C, E, and G). Rx:N-Tcf3-GFP transgenic embryos
o
show loss of both Sox2 and Xdelta-1 expression in the retinal do-
e
main (bracket in [J] and [L]) as compared to control transgenic em-
a
bryos (Rx:GFP) (I and K).
a
*
A
Mrectly into progenitors of the eye primordium in vivo, as
previously described (Holt et al., 1990). Individual la-
beled cells were counted and scored for cell type c
cbased upon morphology and laminar position. To dis-
tinguish between undifferentiated neuroepithelial cells 2
tand Mu¨ller glia, retinal sections were labeled using an
anti-CRALBP antibody, which labels Mu¨ller glia (Bunt- S
sMilam and Saari, 1983). Cotransfection of plasmids en-igure 8. Inhibiting Xfz5 Expression in Retinal Progenitors Biases
ells to Adopt the Mu¨ller Glial Cell Fate
A) Expression of dnXfz5 in retinal progenitors by in vivo lipofection
aused a 4-fold increase in the representation of Mu¨ller glia as
ompared to GFP controls. n = 1706 cells from 26 embryos for GFP,
= 402 cells from 9 embryos for dnXfz5. (B) Retinal section (stage
1) showing a GFP-labeled cell (green) expressing dnXfz5 that is
olabeled using antibodies for the Mu¨ller glial cell marker CRALBP
red). (C) Expression of dnLRP6 in retinal progenitors by in vivo
ipofection also caused a significant increase in the representation
f Mu¨ller glia as compared to GFP controls. n = 391 cells from 6
mbryos for GFP, n = 252 cells from 5 embryos for dnLRP6. For (A)
nd (C), the percent representation of each cell type was calculated
s a weighted average, and error bars represent SEM; **p < 0.001,
p < 0.05 by Student’s t test. G, ganglion cells; H, horizontal cells;
, amacrine cells; B, bipolar cells; PR, photoreceptor cells; M,
u¨ller glial cells.oding dnXfz5 and GFP (Figure 8A) caused a 4-fold in-
rease in the representation of Mu¨ller glia (19.5% ±
.4% SEM; n = 402 cells, 9 embryos) compared to
ransfection of plasmid for GFP alone (5.1% ± 1.1%
EM; n = 1706 cells, 26 embryos). There was a corre-
ponding decrease in other cell types, particularly
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31RGCs and amacrine cells (Figure 8A). Figure 8B shows
an example of a GFP+ cell labeled by the anti-CRALBP
antibody showing the hallmark morphology of a Mu¨ller
glial cell. We also observed significantly fewer GFP-
labeled cells with lipofection of dnXfz5 compared to
GFP control lipofection, consistent with a role for Xfz5
in regulating retinal progenitor proliferation (data not
shown). Since the dnXfz5 receptor may nonspecifically
interfere with signaling through other frizzled receptors,
we also injected the Xfz5 MO into dorsal animal blasto-
meres at the 16-cell stage together with mRNA for
green fluorescent protein (GFP) and scored the retinal
cell type of the GFP-labeled cells as above. Injection of
the Xfz5 MO caused a 3-fold increase in the representa-
tion of CRALBP+ Mu¨ller glia (15% ± 1.0% SEM; n =
2353 cells, 10 embryos) compared to injection of RNA
for GFP alone (5.2% ± 0.5% SEM; n = 1603 cells, 9
embryos), arguing that the effects of dnXfz5 are spe-
cific. Results were also confirmed using an antibody
against the glial marker vimentin (H5 Ab, data not
shown; Herman et al., 1993).
If this bias toward Mu¨ller glial differentiation is due
to a failure to activate Sox2 expression, then directly
suppressing Sox2 expression in retinal progenitors
should have a similar effect. Indeed, when the Sox2MO
was injected into dorsal animal blastomeres at the 16-
cell stage together with mRNA for green fluorescent
protein there was a 3.5-fold increase in Mu¨ller glia
(18.4% ± 1.2% SEM; n = 2177 cells, 10 embryos) com-
pared to injection of RNA for GFP alone (5.2% ± 0.5%
SEM; n = 1603 cells, 9 embryos). There was also a sig-
nificant increase in the representation of RGCs, which
was not observed with the Xfz5 MO, suggesting that
Sox2 may have additional roles in RGC development.
Nevertheless, these results are consistent with our con-
clusion that Xfz5 is regulating commitment to the neural
lineage in part through regulation of Sox2 expression.
Our previous analysis had indicated that TCF/Lef-
dependent signaling likely mediates the effects of Xfz5
in the developing retina. If this is the case, then block-
ing this signaling pathway within individual progenitors
should have similar effects as inhibiting Xfz5. To test
this, we lipofected plasmid for dnLRP6 receptor, which
has a deletion of the cytoplasmic domain and specifi-
cally blocks the Wnt/β-catenin signaling pathway (Fig-
ure 8C; Tamai et al., 2000). Cotransfection of plasmids
encoding dnLRP6 and GFP caused a significant in-
crease in the representation of Mu¨ller glia (18% ± 5.1%
SEM; n = 252 cells, 5 embryos) compared to transfec-
tion of plasmid for GFP alone (1.4% ± 0.5% SEM; n =
391 cells, 6 embryos). Similar effects were observed
using a dominant-negative form of Lef1 or XTCF3 (data
not shown; Kengaku et al., 1998; Molenaar et al., 1996).
These findings are consistent with a role for TCF/Lef-
dependent signaling in mediating the effects of Xfz5
during retinal development.
Discussion
Regional Regulation of Neural Potential
in CNS Progenitors
Within the developing CNS, there are substantial re-
gional differences in the spatial and temporal control ofprogenitor proliferation and differentiation, and it is
likely that this is regulated in part through specific sig-
naling mechanisms that result in fundamental changes
in gene expression within progenitors (Edlund and Jes-
sell, 1999). Our findings support this idea and reveal
that a specific receptor, Xfz5, acting through the canon-
ical Wnt/β-catenin signaling pathway can regulate both
proliferation and neural potential of progenitors selec-
tively in the developing retina, primarily through regu-
lation of Sox2 expression (Figure 9). This reveals an
unanticipated role for Frizzled signaling in neural devel-
opment and raises the possibility that neural potential
in other CNS regions may also be regulated by Frizzled
receptor signaling.
Within the retina, neural potential depends upon ex-
pression of Sox2, the only SoxB1 family member ex-
pressed in this region. Prior to optic vesicle formation,
Sox2 is expressed throughout the neural plate, but we
found that its expression within the emerging optic ves-
icles depends specifically upon Xfz5. Thus, subdo-
mains of Sox2 expression can be selectively regulated,
allowing extrinsic signals to regulate neural potential
and thus the spatial and temporal patterns of neuro-
genesis within a given region. Consistent with this,
analysis of chicken Sox2 gene regulatory regions re-
vealed that its expression is regulated by five con-
served enhancers that each function within different
regions of the nervous system, including one that regu-
lates expression within the developing eye (Uchikawa
et al., 2003). The specific factors and signals that gov-
ern the activity of these enhancers remain to be de-
fined, although our findings predict that in Xenopus, ex-
pression of the retinal Sox2 enhancer will depend
upon Xfz5.
In addition to Xfz5, other signaling pathways are
likely to contribute to regulation of Sox2 expression
within the developing eye. For example, in the lens ec-
toderm of mouse, Sox2 expression depends upon BMP4
signals derived from the distal optic vesicle (Furuta and
Hogan, 1998). Treatment of oligodendrocyte precursors
with BMP2 induces the expression of Sox2 and con-
verts these precursors to multipotent neural stem-like
cells capable of generating both neurons and glia
(Kondo and Raff, 2004). It is likely that additional signal-
ing mechanisms will be found to influence the expres-
sion of this important regulator of neural development.
Sox2 Is Required for Retinal Neurogenesis
We found that Sox2 was required in the developing ret-
ina for progenitors to acquire neural potential and initi-
ate the genes required for neurogenesis. This is consis-
tent with previous work showing that SoxB1 genes are
required for neural determination in both vertebrates
and invertebrates. For example, expression of domi-
nant-negative Sox2 in the ectoderm of developing
Xenopus embryos strongly inhibits neural development
(Kishi et al., 2000). Similarly, Drosophila embryos mu-
tant for both of the SoxB1 genes, soxneuro and
dichaete, show defects in CNS neuroblast formation
and loss of proneural gene expression (Overton et al.,
2002). Furthermore, a conditional knockout of the neu-
ral-specific enhancer of Sox2 in mouse causes defects
in the differentiation of adult neural progenitor cells
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ing Retinal Development
(A) During normal development, Xfz5 regu-
lates the expression of Sox2 in retinal pro-
genitors, allowing progenitors to proliferate,
express proneural genes, and ultimately dif-
ferentiate into postmitotic retinal neurons.
(B) When Xfz5 function is blocked, Sox2 ex-
pression is reduced in retinal progenitors, re-
sulting in reduced proliferation, loss of
proneural gene expression, and a bias to-
ward the nonneural Mu¨ller glial fate.(Ferri et al., 2004), while overexpression of Sox1 in cul- X
Ptured neural progenitor cells promotes neural cell fate
determination and differentiation (Kan et al., 2004). T
iAlthough it is clear that SoxB1 genes are required for
neural potential of CNS progenitors, it has been shown X
pin the developing chick spinal cord that sustained ex-
pression of SoxB1 genes suppresses proneural gene S
iexpression and prevents neurogenesis, thus maintain-
ing a population of progenitors (Bylund et al., 2003; n
XGraham et al., 2003). Consistent with this we also found
that overexpression of Sox2 in retinal progenitors pro- p
Tmotes an increase in nonneural Mu¨ller glial cell differen-
tiation, suggesting that retinal differentiation had been g
(delayed or neural fates suppressed (data not shown).
Conversely, blocking SoxB1 function in chick spinal r
ncord progenitors caused cell cycle exit and precocious
neurogenesis (Bylund et al., 2003; Graham et al., 2003). t
tIn these experiments, SoxB1 function was blocked in
progenitors that were already expressing these genes, W
Nsuggesting that downregulation of SoxB1 expression or
function is critical to allow neurogenesis to proceed. s
When Xfz5 or Sox2 was inhibited in the developing Xen- c
opus retina, we did not observe premature neurogen- p
esis, but rather inhibition of neurogenesis. These find- i
ings are not inconsistent with those in chick spinal cord r
studies, since Sox2 was inhibited prior to its expression
in the optic vesicle, thus preventing the acquisition of
neural potential by progenitors in the retina. Together R
Fthese findings show that the temporal regulation of
Sox2 expression within progenitors must be tightly reg- D
Sulated so that it confers neural competence but is then
extinguished to allow neurogenesis to proceed. We g
phave shown that Sox2 expression in the retina is depen-
dent upon Xfz5; however, it is not yet known whether a
eadditional extrinsic signals contribute to the subse-
quent downregulation of Sox2 expression needed to a
tinitiate neurogenesis. Proneural factors, such as Ngn2,
are known to play a key role, since when overexpressed V
Mthese factors can suppress SoxB1 gene expression in
progenitors and promote differentiation (Bylund et al., s
X2003).fz5 Acts through Sox2 to Regulate Neural
otential of Retinal Progenitors
here are likely to be multiple targets for Xfz5 signaling
n the developing retina, raising the question of whether
fz5 is acting primarily through Sox2 to regulate neural
otential and proliferation. We argue that regulation of
ox2 expression is central to the function of Xfz5 since
nhibition of Sox2 reproduced most aspects of the phe-
otype seen with inhibition of Xfz5. In particular, both
fz5 and Sox2 were required for the normal onset of
roneural and neurogenic gene expression in the retina.
his is consistent with the demonstrated role for SoxB1
enes in regulating neural potential in multiple species
Sasai, 2001). However, Xfz5 signaling could also be di-
ectly regulating the expression of more downstream
eural regulatory genes. In cortical progenitors, Ngn1
ranscription was shown to be regulated by Wnt7a ac-
ivity, and it was argued that this was directly through
nt/β-catenin signaling, since TCF/Lef sites within the
gn1 promoter were shown to be important for tran-
criptional activity, and β-catenin could be detected in
omplex with the Ngn1 promoter in cultured cortical
rogenitor cells (Hirabayashi et al., 2004). In the retina,
t remains to be determined which genes are directly
egulated by Xfz5 signaling.
egulation of Neural versus Nonneural
ate in the Developing Retina
uring retinal development, inhibition of either Xfz5 or
ox2 function biased cells toward the nonneural Mu¨ller
lial fate, likely due to a failure to express downstream
roneural genes, which are involved in cell cycle exit
nd neural differentiation. Other factors that limit the
xpression or function of proneural bHLH factors, such
s Notch and Hes1, have also been shown to promote
he Mu¨ller glial fate in the retina (Furukawa et al., 2000;
etter and Moore, 2001). We found that the increase in
u¨ller cell differentiation caused by dnXFz5 could be
uppressed by cotransfection of the proneural gene
ath5, consistent with the idea that the increase in glial
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33differentiation is due to loss of proneural gene expres-
sion (data not shown).
Previously, we had shown that GSK3β, a component
of the Wnt/β-catenin/TCF signaling pathway as well as
other pathways, regulates cell fate decisions in the
Xenopus retina. Specifically, we found that misexpres-
sion of dominant-negative GSK3β in retinal progenitors,
which can activate the Wnt/β-catenin/TCF signaling
pathway, increased the number of RGC's and de-
creased the number of Mu¨ller glia, effects opposite to
those described here in regard to blocking the pathway
(Moore et al., 2002). We showed that GSK3β was acting
posttranslationally to regulate the activity, not expres-
sion, of specific proneural bHLH factors such as XNeu-
roD (Moore et al., 2002). This may or may not involve
the Wnt/β-catenin/TCF signaling pathway. Here we
show that Xfz5 acts earlier in the process by controlling
the expression of Sox2, which is required for the ex-
pression of proneural genes and thus neural fate in the
retina. Thus, modulating either proneural bHLH factor
expression or activity can affect retinal neurogenesis
and cell fate decisions.
Xfz5 and Sox2 Are Required for Retinal
Progenitor Proliferation
Multiple factors are known to contribute to progenitor
proliferation in the developing CNS. Wnt signaling has
been shown to regulate proliferation in multiple tissues,
most often through direct regulation of Cyclin D1 ex-
pression (Megason and McMahon, 2002). While we
found reduced proliferation when Xfz5 was inhibited,
we found that Cyclin D1 expression in the eye was un-
affected. We conclude that the effects on retinal pro-
genitor proliferation are due to loss of Sox2 expression,
since inhibition of Sox2 had similar effects on retinal
progenitor proliferation as inhibition of Xfz5. Consistent
with a role for Sox2 in progenitor proliferation, a condi-
tional knockout of the neural-specific enhancer of Sox2
in mouse caused defects in both the proliferation and
differentiation of adult neural progenitor cells (Ferri et
al., 2004).
However, Sox2 alone is unlikely to be sufficient for
progenitor proliferation. In the retina, multiple factors
regulate retinal progenitor proliferation, including cell
cycle regulators, as well as many early retinal progeni-
tor homeobox transcription factors such as Pax6, Rx,
Six3, Six6, Prox1, and Chx10 (Levine and Green, 2004;
Dyer, 2003; Dyer and Cepko, 2001). We show here that
Sox2 is an essential regulator of retinal precursor prolif-
eration and that it acts either downstream or indepen-
dent of these early progenitor genes. Little is known
about how Sox2 affects neural progenitor proliferation,
but our data raise the possibility that it functions either
as an effector or partner of these previously defined
retinal homeobox factors to regulate proliferation in the
developing retina.
Within the CMZ of the Xenopus retina there is a clear
transition in the proliferative properties of retinal pro-
genitors that is marked by the expression of Xfz5 and
Sox2. The most peripheral stem cells express retinal
progenitor genes such as Rx, Pax6, Six3, and Six6, but
do not express Xfz5 or Sox2 and are slowly proliferat-
ing. These cells will contribute to both the neural retinaand retinal pigment epithelium. More centrally located
cells within the CMZ express all of these genes, includ-
ing Xfz5 and Sox2, are more rapidly proliferating, and
will give rise to cells dedicated to the neural retina
alone. Thus, Xfz5 and Sox2 are associated with both
increased proliferation and commitment to the neural
retina lineage and may regulate this transition within
the CMZ. Retinal stem cells isolated from mammalian
pigmented ciliary body express retinal progenitor
genes such as Pax6 (Tropepe et al., 2000), but it will be
interesting to see whether they also express Sox2 or
whether Sox2 expression can enhance the neural po-
tential or proliferative properties of these cells.
Xfz5 Acts through the Wnt/-Catenin/TCF
Signaling Pathway
Although Frizzled receptors are capable of activating
multiple signaling pathways, we provide several lines of
evidence supporting the conclusion that Xfz5 is acting
through Wnt/β-catenin/TCF signaling. Fz5 is capable of
activating Wnt/β-catenin signaling since it can promote
axis duplication in Xenopus embryos when coex-
pressed with Wnt2, Wnt5a, or Wnt10b (He et al., 1997;
Ishikawa et al., 2001) and can bind to Wnt7a to activate
Wnt/β-catenin signaling in PC12 cells (Caricasole et al.,
2003). The Wnt ligand responsible for activating Xfz5 in
the developing retina remains to be defined.
Previous work has demonstrated that in the chick ret-
ina Wnt2b, likely through Wnt/β-catenin signaling, in-
hibits differentiation, induces proliferation, and main-
tains expression of retinal progenitor cell markers,
suggesting that Wnt2b has an important function in
maintaining undifferentiated retinal progenitors (Kubo
et al., 2003; Nakagawa et al., 2003). In other regions of
the developing CNS, Wnt/β-catenin signaling can also
regulate neuroepithelial precursor proliferation and
maintain cells in an undifferentiated state (Megason
and McMahon, 2002). These findings are not necessar-
ily inconsistent with ours. Recent evidence argues that
Wnt/Fz signaling can act at multiple steps in develop-
ment. For example, in the developing cerebral cortex,
stimulation with Wnt7a or activation of Wnt/β-catenin
signaling in precursors from e13.5 neocortex promotes
neuronal differentiation, while activation of Wnt/β-ca-
tenin signaling in precursors from earlier stages (e10.5)
suppresses differentiation, suggesting that the effects
of Wnt/β-catenin are stage dependent (Hirabayashi et
al., 2004). We propose that during vertebrate eye devel-
opment Wnt/Fz signaling may have multiple roles. It
may act to maintain a population of undifferentiated
progenitors, as suggested by Kubo et al. (2003), or pro-
mote more peripheral fates at the margins of the CMZ,
and then also regulate neural potential and increased
proliferation, as shown here. Consistent with this
model, we find that components of the Wnt/β-catenin
signaling pathway, such as β-catenin and TCF3, are ex-
pressed throughout the CMZ of the Xenopus retina, in-
cluding in the most peripheral progenitor cells (T.J.V.R.
and M.LV., unpublished data), while Xfz5 is excluded
from this most peripheral cell population. However, it
also remains possible that there are significant species
differences with respect to the role of the Wnt/β-catenin
signaling pathway during eye development. Together
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Rspecific role in regulating neural potential and prolifera-
Ation of progenitors in the developing Xenopus retina.
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Experimental Procedures R
Morpholino Injections B
10 ng of MO (Gene Tools; Philomath, OR) were injected into one S
dorsal animal (D1) blastomere at the 8-cell stage and coinjected b
with RNA encoding eGFP (1 ng), or β-galactosidase (250 pg), and c
selected for marker expression in the eye region. See Table S1 for
B
MO sequence.
b
n
Transgenic Procedure B
The generation of transgenics was carried out as described in Kroll c
and Amaya (1996) with variations described in Hutcheson and Vet- C
ter (2002). Whole-mount antibody staining was performed using a
Brabbit anti-GFP antibody (Torrey Pines) and an Alexa-Fluor 488-
Nconjugated secondary antibody (Molecular Probes). The TOP:dGFP
Oconstruct was a gift from R. Dorsky (Dorsky et al., 2002).
i
t
In Situ Hybridization B
In situ hybridization with digoxigenin-labeled anti-sense mRNA i
probes was performed as previously described (Kanekar et al.,
B1997) with the following probes: Xash3 (Zimmerman et al., 1993),
bXath5 (Kanekar et al., 1997), Xbrn3d (Hutcheson and Vetter, 2001),
rXdelta-1 (Dorsky et al., 1997), Rx1 (Mathers et al., 1997), Xnotch-1
C(Coffman et al., 1990), en-2 (Hemmati-Brivanlou et al., 1991), X-ngnr-1
M(Ma et al., 1996), Xfz5 (Sumanas and Ekker, 2001), Sox2 (Mizuseki
cet al., 1998), Xpax6 (Hirsch and Harris, 1997), Xsix3 (Zhou et al.,
A2000), and Xsix6 (or XOptx2; Zuber et al., 1999).
t
CHP3 Antibody Staining and BrDU Labeling
hAnti-HP3 staining was performed as previously described (Burns
and Vetter, 2002). BrDU labeling was performed as previously de- C
scribed (Perron et al., 1998), and staining was performed using a s
BrDU In-Situ Detection Kit (BD Biosciences, San Diego, CA). t
D
aIn Vivo Lipofection of DNA and Retinal Cell Fate Analysis
BThe dominant-negative Xfz5 (dnXfz5) construct was generated by
PCR amplification of the extracellular domain, which was sub- D
cloned into pCS2+ (Turner and Weintraub, 1994). The dnLef1 con- c
struct was a gift from S. Nakagawa (Kengaku et al., 1998), the D
dnLRP6 construct was from Dr. F. Cavodeassi (Tamai et al., 2000), R
and the dnTCF-3 construct was from Dr. J. Venuti (Molenaar et al., n
1996). Retinal lipofections were peformed as previously described
D(Moore et al., 2002).
L
s
Immunostaining on Retinal Sections 2
Cryosections of stage 41 embryos were stained with mouse anti-
D
rhodopsin (1:100); mouse anti-vimentin (H5 at 1:100, from Develop-
a
mental Studies Hybridoma Bank, University of Iowa; Herman et al.,
C
1993), rabbit anti-Pax6 (1:250), or anti-CRALBP (1:1000; a gift from
DDr. J. Saari) as previously described (Moore et al., 2002).
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